Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 938 of 1,261
  1. US 8093382

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  2. US 8093354

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  3. US 8093403

    Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same

    Takeda Pharmaceutical Company Limited · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  4. US 8093291

    Methods of using and compositions comprising tryptophan hydroxylase inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  5. US 8093343

    Nitric oxide-releasing diazeniumdiolated compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  6. US 8093280

    Methods of preparing imidazole-based compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  7. US 8093267

    Methods of treating rheumatoid arthritis

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  8. US 8093246

    O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  9. US 8093392

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  10. US 8093245

    4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  11. US 8093214

    Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  12. US 8092838

    Use of hydrogen sulfide in the treatment of eye diseases

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  13. US 8092988

    Medium and method of deriving and using a mutated bacteria strain

    United States of America as represented by the Secretary of the Air Force · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  14. US 8092812

    Methods and compositions for immunization against chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  15. US 8092803

    VEGF antagonist formulations for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  16. US 8092796

    Monoclonal antibodies against ANGPTL4

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  17. US 8092809

    Pseudomonas exotoxin A-like chimeric immunogens

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  18. US 8092830

    Lactic acid polymer and process for producing the same

    Takeda Pharmaceutical Company Limited · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  19. US 8093286

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  20. US 8092802

    High affinity human antibodies to human IL-4 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  21. US 8093274

    Inhibitors of protein prenyltransferases

    The Regents of the University of California · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  22. US 2012003230

    SUSTAINED RELEASE DRUG DELIVERY SYSTEMS COMPRISING A WATER SOLUBLE THERAPEUTIC AGENT AND A RELEASE MODIFIER

    TROGDEN JOHN T [US] · Granted Jan 5, 2012 · Expires Dec 31, 2031

    granted
  23. US 8088365

    Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution

    Nektar Therapeutics · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted
  24. US 8088759

    1,4-benzodiazepine-2,5-diones with therapeutic properties

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.